Clinical Effectiveness and Safety Comparison between Reduced Rivaroxaban Dose and Dual Antiplatelet Therapy for Nonvalvular Atrial Fibrillation Patients Following Percutaneous Left Atrial Appendage Closure: A Prospective Observational Study.
Xiaoye LiQinchun JinYao YaoXiaochun ZhangQianzhou LvPublished in: Reviews in cardiovascular medicine (2023)
After successful closure implantation, long-term RRD significantly reduced the DRT and TE occurrence compared with DAPT.
Keyphrases
- atrial fibrillation
- left atrial appendage
- antiplatelet therapy
- percutaneous coronary intervention
- catheter ablation
- oral anticoagulants
- acute coronary syndrome
- left atrial
- end stage renal disease
- direct oral anticoagulants
- heart failure
- ejection fraction
- chronic kidney disease
- newly diagnosed
- venous thromboembolism
- risk assessment
- prognostic factors
- pulmonary embolism
- ultrasound guided
- patient reported